Glucocorticoids as a biological substrate of reward: Physiological and pathophysiological implications

Brain Research Reviews

Volumn 25, Issue 3, 1997, Pages 359-372

  Piazza, Pier Vincenzo ^a   Le Moal, Michel ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CORTICOSTERONE; DOPAMINE; GLUCOCORTICOID; OPIATE; PSYCHOSTIMULANT AGENT; TYROSINE 3 MONOOXYGENASE;

ADAPTATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; DOPAMINE RELEASE; DRUG ABUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REINFORCEMENT; REVIEW; REWARD; STRESS; THREAT;

ANIMALS; GLUCOCORTICOIDS; HUMANS; REWARD; STRESS, PSYCHOLOGICAL;

EID: 0031431678     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00025-8     Document Type: Review

References (99)

1. Antelman S.M., Eichler A.J., Black C.A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 207:1980;329-331.
2. Badiani A., Morano I., Akil H., Robinson T.E. Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine. Brain Res. 673:1995;13-24.
3. Barbazanges A., Piazza P.V., Le Moal M., Maccari S. Maternal glucocorticoid secretion mediates long term effects of prenatal stress. J. Neurosci. 6:1996;3943-3949.
4. Bohus B., De Kloet E.R., Veldhuis H.D. Adrenal steroids and behavioral adaptation: relationship to brain corticoid receptors. Curr. Topics Neuroendocrinol. 2:1982;107-148.
5. Bronson F.H., Desjardins C. Endocrine Response to sexual arousal in mice. Endocrinology. 111:1982;1286-1291.
6. Caesar P.M., Collins G.G.S., Sandler M. Catecholamine metabolism and monoamine oxidase activity in adrenalectomized rats. Biochem. Pharmacol. 19:1970;921-926.
7. Caggiula A.R., Epstein L.H., Antelman S.M., Saylor S.S., Perkins K.A., Knopf S., Stiller R. Conditioned tollerance to the anorectic and corticosterone-elevating effects of nicotine. Pharmacol. Biochem. Behav. 40:1991;53-59.
8. Crombag H.S., Badiani A., Robinson T.E. Signalled versus unsignalled intravenous amphetamine: large differences in the acute psychomotor response and sensitization. Brain Res. 722:1996;227-231.
9. De Kloet E.R. Brain corticosteroid receptors balance and homeostatic control. Frontiers Neuroendocrinol. 12:1991;95-164.
10. De Kloet E.R., De Kock S., Schild V., Veldhuis D. Antiglucocorticoid RU38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites. Neuroendocrinology. 47:1988;109-115.
11. Dellu F., Mayo P.W., Piazza P.V., Le Moal M., Simon H. Individual differences in behavioral responses to novelty in rats. Possible relationship with the sensation-seeking trait in man. Person. Individ. Diff. 15:1993;411-418.
12. Deminière J.M., Piazza P.V., Guegan G., Abrous N., Maccari S., Le Moal M., Simon H. Increased locomotor response to novelty and propensity to intravenous self-administration in adult offspring of stressed mothers. Brain Res. 586:1992;135-139.
13. Deroche V., Marinelli M., Le Moal M., Piazza P.V. Glucocorticoids and behavioral effects of psychostimulants. II: Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J. Pharm. Exp. Ther. 281:1997;1401-1407.
14. Deroche V., Marinelli M., Maccari S., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7181-7188.
15. Deroche V., Piazza P.V., Casolini P., Le Moal M., Simon H. Sensitization to the psychomotor effects of amphetamine and morphine induced by food restriction depends on corticosterone secretion. Brain Res. 611:1993;352-356.
16. Deroche V., Piazza P.V., Casolini P., Maccari S., Le Moal M., Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res. 598:1992;343-348.
17. Deroche V., Piazza P.V., Deminière J.M., Le Moal M., Simon H. Rats orally self-administer corticosterone. Brain Res. 622:1993;315-320.
18. Deroche V., Piazza P.V., Le Moal M., Simon H. Individual differences in the psychomotor effects of morphine are predicted by reactivity to novelty and influenced by corticosterone secretion. Brain Res. 623:1993;341-344.
19. Deroche V., Piazza P.V., Le Moal M., Simon H. Social isolation-induced enhancement of the psychomotor effects of morphine depends on corticosterone secretion. Brain. 640:1994;136-139.
20. Deroche V., Piazza P.V., Maccari S., Le Moal M., Simon H. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res. 584:1982;309-313.
21. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
22. Dixon R.B., Christy N.P. On the various forms of corticosteroid withdrawal syndrome. Am. J. Med. 68:1980;224-230.
23. Dunn A.J., Gildersleeve N.B., Gray H.E. Mouse brain tyrosine hydroxylase and glutamic acid decarboxylase following treatment with adrenocorticotrophic hormone, vasopressin or corticosterone. J. Neurochem. 31:1978;977-982.
24. Ettenberg A., Sgro S., White N. Algebraic summation of the affective properties of a rewarding and aversive stimuli in the rat. Physiol. Behav. 28:1982;873-877.
25. Fahlke C., Hard E., Eriksson C.J.P., Engel J.A., Hansen S. Consequences of long term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists. Psychopharmacology. 117:1995;216-224.
26. Fibiger H.C., Phillips A.G. Mesocorticolimbic dopamine systems and reward. Ann. NY Acad. Sci. 537:1988;206-215.
27. Fuller R.W., Snody H.D. Elevation of serum corticosterone by pergolide and other dopaminergic agonists. Endocrinology. 109:1981;1026-1032.
28. Gilad G.M., Rabey J.M., Gilad V.H. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci. 40:1987;2401-2408.
29. Hall R.C.W., Popkin M.K., Stickney S.K., Gardner E.R. Presentation of steroid psychoses. J. Nerv. Ment. Dis. 167:1979;229-236.
30. Haney M., Maccari S., Le Moal M., Simon H., Piazza P.V. Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res. 698:1995;46-52.
31. Härfstrand A., Fuxe K., Cintra A., Agnati A.F., Zini I., Wilkström A.C., Okret S., Yu Z.Y., Goldstein M., Steinbuch H., Verhöfstad A., Gustafsson J.A. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc. Natl. Acad. Sci. USA. 83:1986;9779-9783.
32. Honma K., Honma S., Hiroshige T. Feeding-associated corticosterone peak in rats under various feeding cycles. Am. J. Physiol. 246:1984;R721-R726.
33. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., Justice J.B. Jr. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse. 9:1991;121-128.
34. Ho-Van-Hap A., Babineau L.M., Berlinguet L. Hormonal action on monoamine oxidase activity in rats. Can. J. Biochem. 45:1967;355.
35. Imperato A., Puglisi-Allegra S., Casolini P., Angelucci L. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 538:1991;111-117.
36. Iuvone P.M., Morasco J., Dunn A.J. Effect of corticosterone on the synthesis of [3H]catecholamines in the brains of CD-1 mice. Brain Res. 120:1977;571-576.
37. Iversen L.L., Salt P.J. Inhibition of catecholamine uptake by steroids in the isolated rat heart. Br. J. Pharmacol. 40:1970;528-530.
38. Jefferys D., Copolov D., Irby D., Funder J. Behavioural effect of adrenalectomy: reversal by glucocorticoids or [D-AlaMet]enkephalinamide]. Eur. J. Pharmacol. 92:1983;99-103.
39. Jefferys D., Funder J.W. Glucocorticoids, adrenal medullary opioids, and the retention of a behavioral response after stress. Endocrinology. 21:1987;1006-1009.
40. Joëls M., De Kloet E.R. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 15:1992;25-30.
41. Joëls M., de Kloet E.R. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog. Neurobiol. 43:1994;1-36.
42. Joyce E.M., Iversen S.D. The effect of morphine applied locally to mesencephalic dopamine cell bodies on spontaneous motor activity in the rat. Neurosci. Lett. 14:1979;207-212.
43. Kalivas P.W., Widerlöv E., Stanley D., Breese G., Prange A.J. Jr. Enkephalin action on the mesolimbic system: a dopamine-dependent and dopamine-independent increase in locomotor activity. J. Pharmacol. Exp. Ther. 227:1983;229-237.
44. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
45. Kelly P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40:1976;45-56.
46. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
47. Krieger D.T. Food and water restriction shifts corticosterone temperature activity and brain amine periodicity. Endocrinology. 95:1974;1195-1201.
48. Kumar B.A., Leibowitz S.F. Impact of acute corticosterone administration on feeding and macronutrient self-selection patterns. Am. J. Physiol. 254:1988;R222-R228.
49. Le Moal M., Simon H. Mesocorticolimbic dopamine network: functional and regulatory roles. Physiol. Rev. 71:1991;155-234.
50. Ling M.H.M., Perry P.J., Tsuang M.T. Side effects of corticosteroid therapy. Arch. Gen. Psychiatry. 38:1981;471-477.
51. Lowy T.M. MK-801 antagonizes methamphetamine induced decreases in hippocampal and striatal corticosteroid receptors. Brain Res. 533:1990;348-352.
52. Maccari S., Piazza P.V., Deminière J.M., Lemaire V., Mormède P., Simon H., Angelucci L., Le Moal M. Life events-induced decrease of type I corticosteroid receptors is associated with a decrease of corticosterone feedback and an increase of the vulnerability to amphetamine self-administration. Brain Res. 547:1991;7-12.
53. Maccari S., Piazza P.V., Kabbaj M., Barbazanges A., Simon H., Le Moal M. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J. Neurosci. 15:1995;110-116.
54. Manzo C., Zerani M., Gobbetti A., Di Fiore M.M., Angelini F. Is corticosterone involved in the reproductive process of the male lizard, Podarcis sicula sicula? Horm. Behav. 28:1994;117-129.
55. Marinelli M., Piazza P.V., Deroche V., Maccari S., Le Moal M., Simon H. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J. Neurosci. 14:1994;2724-2731.
56. Markey K.A., Towle A.C., Sze P.Y. Glucocorticoid influence on tyrosine hydroxylase activity in mouse locus coeruleus during postnatal development. Endocrinology. 111:1982;1519-1523.
57. McEwen B.S., De Kloet E.R., Rostène W. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66:1986;1121-1128.
58. Micco D.J. Jr., McEwen B.S., Shein W. Modulation of behavioural inhibition in appetitive extinction following manipulation of adrenal steroids in rats: implications for involvement of the hippocampus. J. Comp. Physiol. Psychol. 93:1979;323-329.
59. Mitchell J.B., Meaney M.J. Effects of corticosterone on response consolidation and retrieval in the forced swim test. Behav. Neurosci. 105:1991;798-803.
60. Mittleman G.M., Blaha C.D., Phillips A.G. Pituitary-adrenal and dopaminergic modulation of schedule-induced polydipsia: behavioral and neurochemical evidence. Behav. Neurosci. 106:1992;402-408.
61. Munch A., Guyre P.M., Holbrook N.J. Physiological function of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev. 5:1984;25-44.
62. Oitzl M.S., de Kloet E.R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 1:1992;62-71.
63. Olds J., Milner P.M. Positive reinforcement produced by electrical stimulation of septal area and other regions of the brain. J. Comp. Physiol. Psychol. 47:1954;419-427.
64. Orchinic M., Licht P., Crews D. Plasma steroid concentrations change in response to sexual behavior in Bufo marinus. Horm. Behav. 22:1988;338-350.
65. Ortiz J., De Caprio J.L., Kosten T.A., Nestler E.J. Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience. 67:1995;383-397.
66. Parvez H., Parvez S. The regulation of monoamino oxidase by adrenal cortical steroids. Acta Endocrinol. 73:1973;509-517.
67. Piazza P.V., Barrot M., Rougé-Pont F., Marinelli M., Maccari S., Abrous D.N., Simon H., Le Moal M. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc. Natl. Acad. Sci. USA. 93:1996;15445-15450.
68. Piazza P.V., Deminière J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
69. Piazza P.V., Deroche V., Deminière J.M., Maccari S., Le Moal M., Simon H. Reinforcing properties of corticosterone demonstrated by intravenous self-administration. Possible biological basis of sensation-seeking. Proc. Natl. Acad. Sci. USA. 90:1993;11738-11742.
70. Piazza P.V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 36:1996;359-378.
71. Piazza P.V., Maccari S., Deminière J.M., Le Moal M., Mormède P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. USA. 88:1991;2088-2092.
72. Piazza P.V., Marinelli M., Jodogne C., Deroche V., Rougé-Pont F., Maccari S., Le Moal M., Simon H. Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res. 658:1994;259-264.
73. Piazza P.V., Rougé-Pont F., Deminière J.M., Kharouby M., Le Moal M., Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567:1991;169-174.
74. Piazza P.V., Rougé-Pont F., Deroche V., Maccari S., Simon S., Le Moal M. Glucocorticoids have state dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc. Natl. Acad. Sci. USA. 93:1996;8716-8720.
75. L.W. Reiser, M.F. Reiser, Endocrine disorders. In: H.I. Kaplan, B.J. Sadock (Eds.), Comprehensive Textbook of Psychiatry/IV, William and Wilkins, Baltimore, 1995, pp. 1170-1171.
76. Robbins T.W., Everitt B.J. Neurobehavioural mechanisms of reward and motivation. Curr. Opin. Neurobiol. 6:1996;228-236.
77. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
78. Rothschild A.J., Langlais P.J., Schatzberg A.F., Miller M.M., Saloman M.S., Lerbinger J.E., Cole J.O., Bird E. The effect of a single acute dose of dexamethasone on monoamine and metabolite levels in the rat brain. Life Sci. 36:1985;2491-2505.
79. Rougé-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J. Neurosci. 15:1995;7189-7195.
80. Rougé-Pont F., Piazza P.V., Kharouby M., Le Moal M., Simon H. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study. Brain Res. 602:1993;169-174.
81. Seiden L.S., Sabol K.E., Ricarte G.A. Amphetamine effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33(1993):1993;639-677.
82. H. Selye, Stress: The Physiology and the Pathology of Exposure to Stress, Acta Medica Publication, Montreal, 1950.
83. Silva M.T.A. Effects of adrenal demedullation and adrenalectomy on an active avoidance response of rats. Physiol. Psychol. 2:1974;171-174.
84. Solomon R.L., Corbit R. An opponent-process theory of motivation: temporal dynamics of effects. Psychol. Rev. 81:1974;119-145.
85. Szekely J.I. Opioid peptides and stress. Crit. Rev. Neurobiol. 6:1990;1-12.
86. Taylor G.T., Weiss J., Rupich R. Male rat behavior, endocrinology and reproductive physiology in a mixed-sex, socially stressful colony. Physiol. Behav. 39:1987;429-433.
87. Trudeau L.-E., Argon C.M.G., Amit Z. Effects of ethanol on locomotor depression and corticosterone release induced by restraint-stress: support for a stress ethanol interaction. Pharmacol. Biochem. Behav. 36:1990;273-278.
88. Veals J.W., Korduba C.A., Symchowicz S. Effect of dexamethasone on monamine oxidase inhibition by iproniazid in rat brain. Eur. J. Pharmacol. 41:1977;291-299.
89. Versteeg D.H.G., Van Zoest I., De Kloet E.R. Acute changes in dopamine metabolism in the medial basal hypothalamus following adrenalectomy. Experentia. 40:1983;112-114.
90. D. Von Zersen, Mood and behavioural changes under corticosteroid therapy, In: T.M. Itel, G. Laudahn, W.M. Herman (Eds.), Psychotropic Action of Hormones, Spectrum, New York, 1976, pp. 195-214.
91. Weeks J.R. Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science. 138:1962;143-144.
92. Weiss J.M., McEwen B.S., Silva M.T., Kalkut M. Pituitary-adrenal alterations and fear responding. Am. J. Physiol. 218:1970;864-868.
93. Williams P.B., Hudgins P.M. Action of hydrocortisone, desoxycortisone acetate and progesterone on 14C-norepinephrine uptake and metabolism by rabbit aorta. Pharmacology. 9:1973;262-269.
94. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6:1996;243-251.
95. Wise R.A., Rompre P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
96. R.A. Yokel, Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preferences, In: M.A. Bozarth (Eds.), Methods of Assessing the Reinforcing Properties of Abused Drugs, Spring-Verlag, New York, 1987, pp. 1-34.
97. M. Zuckerman, In: J. Engel, L. Oreland (Eds.), Brain Reward Systems and Abuse, Raven Press, New York, 1987, pp. 165-182.
98. Zerani M., Gobbetti A. Corticosterone during the annual reproductive cycle and in sexual behavior in the crested newt, Triturus carnifex. Horm. Behav. 27:1993;29-37.
99. Zuckerman M. Sensation seeking: A comparative approach to a human trait. Behav. Brain Sci. 7:1984;413-471.